Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-18-006156)

Filing Details

Accession Number:: 0001225208-18-006156
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-14 17:19:58
Reporting Period:: 2018-03-13

Accepted Time:: 2018-03-14 17:19:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1594762	A Rady Johnson	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-03-13	169	$36.59	70,332	No	4	S	Direct
Common Stock	Disposition	2018-03-13	700	$36.57	69,632	No	4	S	Direct
Common Stock	Disposition	2018-03-13	1,600	$36.51	68,032	No	4	S	Direct
Common Stock	Disposition	2018-03-13	2,200	$36.60	65,832	No	4	S	Direct
Common Stock	Disposition	2018-03-13	2,700	$36.52	63,132	No	4	S	Direct
Common Stock	Disposition	2018-03-13	2,854	$36.56	60,278	No	4	S	Direct
Common Stock	Disposition	2018-03-13	3,100	$36.53	57,178	No	4	S	Direct
Common Stock	Disposition	2018-03-13	3,200	$36.58	53,978	No	4	S	Direct
Common Stock	Disposition	2018-03-13	3,800	$36.54	50,178	No	4	S	Direct
Common Stock	Disposition	2018-03-13	7,000	$36.55	43,178	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,001	Indirect	By Rule 16b-3 Plan